Linked Life Data

17484890

Source:http://linkedlifedata.com/resource/pubmed/id/17484890

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17484890rdf:typepubmed:Citationlld:pubmed
pubmed-article:17484890lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:17484890lifeskim:mentionsumls-concept:C0023675lld:lifeskim
pubmed-article:17484890lifeskim:mentionsumls-concept:C0280274lld:lifeskim
pubmed-article:17484890lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:17484890pubmed:issue5lld:pubmed
pubmed-article:17484890pubmed:dateCreated2007-5-8lld:pubmed
pubmed-article:17484890pubmed:abstractTextThe burden of disease consequent to hepatitis C virus (HCV) infection has been well described and is expected to increase dramatically over the next decade. Current approved antiviral therapies are effective in eradicating the virus in approximately 50% of infected patients. However, pegylated interferon and ribavirin-based therapy is costly, prolonged, associated with significant adverse effects, and not deemed suitable for many HCV-infected patients. As such, there is a clear and pressing need for the development of additional agents that act through alternate or different mechanisms, in the hope that such regimens could lead to enhanced response rates more broadly applicable to patients with hepatitis C infection. Recent basic science enhancements in HCV cell culture systems and replication assays have led to a broadening of our understanding of many of the mechanisms of HCV replication and, therefore, potential novel antiviral targets. In this article, we have attempted to highlight important new information as it relates to our understanding of the HCV life cycle. These steps broadly encompass viral attachment, entry, and fusion; viral RNA translation; posttranslational processing; HCV replication; and viral assembly and release. In each of these areas, we present up-to-date knowledge of the relevant aspects of that component of the viral life cycle and then describe the preclinical and clinical development targets and pathways being explored in the translational and clinical settings.lld:pubmed
pubmed-article:17484890pubmed:languageenglld:pubmed
pubmed-article:17484890pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17484890pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17484890pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17484890pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17484890pubmed:statusMEDLINElld:pubmed
pubmed-article:17484890pubmed:monthMaylld:pubmed
pubmed-article:17484890pubmed:issn0016-5085lld:pubmed
pubmed-article:17484890pubmed:authorpubmed-author:McHutchisonJo...lld:pubmed
pubmed-article:17484890pubmed:authorpubmed-author:PawlotskyJean...lld:pubmed
pubmed-article:17484890pubmed:authorpubmed-author:ChevaliezStép...lld:pubmed
pubmed-article:17484890pubmed:issnTypePrintlld:pubmed
pubmed-article:17484890pubmed:volume132lld:pubmed
pubmed-article:17484890pubmed:ownerNLMlld:pubmed
pubmed-article:17484890pubmed:authorsCompleteYlld:pubmed
pubmed-article:17484890pubmed:pagination1979-98lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:meshHeadingpubmed-meshheading:17484890...lld:pubmed
pubmed-article:17484890pubmed:year2007lld:pubmed
pubmed-article:17484890pubmed:articleTitleThe hepatitis C virus life cycle as a target for new antiviral therapies.lld:pubmed
pubmed-article:17484890pubmed:affiliationFrench National Reference Center for Viral Hepatitis B, C, and delta, Department of Virology, Hôpital Henri Mondor, Université Paris 12, Créteil, France. jean-michel.pawlotsky@hmn.aphp.frlld:pubmed
pubmed-article:17484890pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17484890pubmed:publicationTypeReviewlld:pubmed
pubmed-article:17484890pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17484890lld:pubmed